- Home
- PHAT vs GES Comparison
PHAT vs GES Comparison
Compare PHAT & GES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- GES
- Stock Information
- Founded
- PHAT 2018
- GES 1981
- Country
- PHAT United States
- GES Switzerland
- Employees
- PHAT N/A
- GES N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- GES Apparel
- Sector
- PHAT Health Care
- GES Consumer Discretionary
- Exchange
- PHAT Nasdaq
- GES Nasdaq
- Market Cap
- PHAT 942.6M
- GES 872.4M
- IPO Year
- PHAT 2019
- GES 1996
- Fundamental
- Price
- PHAT $14.85
- GES $16.92
- Analyst Decision
- PHAT Strong Buy
- GES Buy
- Analyst Count
- PHAT 5
- GES 5
- Target Price
- PHAT $17.60
- GES $19.25
- AVG Volume (30 Days)
- PHAT 983.2K
- GES 517.6K
- Earning Date
- PHAT 10-30-2025
- GES 11-25-2025
- Dividend Yield
- PHAT N/A
- GES 5.32%
- EPS Growth
- PHAT N/A
- GES N/A
- EPS
- PHAT N/A
- GES 0.35
- Revenue
- PHAT $147,190,000.00
- GES $3,091,508,000.00
- Revenue This Year
- PHAT $218.38
- GES $7.97
- Revenue Next Year
- PHAT $87.14
- GES $3.46
- P/E Ratio
- PHAT N/A
- GES $48.79
- Revenue Growth
- PHAT 460.30
- GES 7.84
- 52 Week Low
- PHAT $2.21
- GES $8.48
- 52 Week High
- PHAT $16.08
- GES $18.07
- Technical
- Relative Strength Index (RSI)
- PHAT 64.62
- GES 53.86
- Support Level
- PHAT $14.12
- GES $16.79
- Resistance Level
- PHAT $15.28
- GES $17.07
- Average True Range (ATR)
- PHAT 0.93
- GES 0.10
- MACD
- PHAT 0.07
- GES -0.03
- Stochastic Oscillator
- PHAT 82.58
- GES 44.64
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About GES Guess? Inc.
Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.